{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:23:33Z","timestamp":1795022613135,"version":"4.10.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To analyze whether different volumes of tissue resected during transurethral resection of the prostate (TURP) would associate with the subsequent development of prostate cancer.<\/jats:p>\n            <jats:p>This population-based retrospective cohort study recruited 49,206 patients with benign prostate hyperplasia (BPH) undergoing TURP between 2005 and 2012. Patients were recruited from the Taiwan National Health Insurance Research Database. Patients were separated into three groups, based on different volumes of tissue resected during TURP (5\u201315\u200ag, 15\u201350\u200ag, &gt;50\u200ag).<\/jats:p>\n            <jats:p>Of the 49,206 patients, 633 patients were diagnosed with new onset of prostate cancer following TURP. Older age was a risk factor contributing to the onset of prostate cancer (<jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.0196) and different volumes of tissue resected were significantly related to the incidence of postoperative prostate cancer (<jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.0399). The group of patients with a smaller volume of prostate resected had a higher risk of prostate cancer with a hazard ratio (HR) of 1.221 (95% confidence interval [CI]: 1.035, 1.440; <jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.0179). However, the risk in the group of patients with a larger volume of prostrate resected was not significantly different, with an HR of 1.277 (95% CI: 0.981, 1662; <jats:italic toggle=\"yes\">P\u200a=\u200a<\/jats:italic>.0690). The incidence of prostate cancer in Taiwanese males over 30 years of age has previously been reported to be 0.0560%; the mean incidence was 0.2282% in our present study.<\/jats:p>\n            <jats:p>This study shows that BPH patients who had a smaller volume of tissue resected during TURP show a higher incidence of prostate cancer postoperatively. Currently, no clear mechanism is shown to demonstrate the relationship between resected prostate weight and the incidence of tumors. Patients with a larger prostate volume might have lower urinary tract symptoms earlier and then seek professional help. It is possible that surgical procedures might remove the potentially carcinogenic prostate tissue and thus reduce the risk of an aggressive tumor developing in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013897","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T03:06:45Z","timestamp":1547694405000},"page":"e13897","source":"Crossref","is-referenced-by-count":18,"title":["Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate"],"prefix":"10.1097","volume":"98","author":[{"given":"Fu-Chao","family":"Liu","sequence":"first","affiliation":[{"name":"The Department of Anesthesiology, Chang Gung Memorial Hospital"},{"name":"College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chun","family":"Hua","sequence":"additional","affiliation":[{"name":"The Department of Anesthesiology, Chang Gung Memorial Hospital"},{"name":"College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jr-Rung","family":"Lin","sequence":"additional","affiliation":[{"name":"Clinical Informatics and Medical Statistics Research Center and Graduate Institute of Clinical Medicine, Chang Gung University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See-Tong","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Urology, Chang Gung Memorial Hospital, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Ping","family":"Yu","sequence":"additional","affiliation":[{"name":"The Department of Anesthesiology, Chang Gung Memorial Hospital"},{"name":"College of Medicine"},{"name":"Department of Anesthesiology, Xiamen Chang Gung Hospital, Xiamen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"(1 suppl)","key":"R2-20230914","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4","article-title":"The association of benign prostatic hyperplasia and cancer of the prostate","volume":"70","author":"Bostwick","year":"1992","journal-title":"Cancer"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.epirev.a000782","article-title":"Benign prostatic hyperplasia and prostate cancer","volume":"23","author":"Guess","year":"2001","journal-title":"Epidemiol Rev"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The link between benign prostatic hyperplasia and prostate cancer","volume":"10","author":"Orsted","year":"2013","journal-title":"Nat Rev Urol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.eururo.2008.11.011","article-title":"Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? findings of a literature review","volume":"55","author":"Alcaraz","year":"2009","journal-title":"Eur Urol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"De Nunzio","year":"2012","journal-title":"Eur Urol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.epirev.a000780","article-title":"Natural history of prostate cancer\u2014epidemiologic considerations","volume":"23","author":"Miller","year":"2001","journal-title":"Epidemiol Rev"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(74)91551-7","article-title":"Relation between benign prostatic hyperplasia and cancer of the prostate","volume":"304","author":"Armenian","year":"1974","journal-title":"Lancet"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jnci\/53.2.335","article-title":"Cancer of the prostate among men with benign prostatic hyperplasia","volume":"53","author":"Greenwald","year":"1974","journal-title":"J Natl Cancer Inst"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/oxfordjournals.aje.a116858","article-title":"The relation of surgery for prostatic hypertrophy to carcinoma of the prostate","volume":"138","author":"Simons","year":"1993","journal-title":"Am J Epidemiol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/aje\/kwq493","article-title":"Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial","volume":"173","author":"Schenk","year":"2011","journal-title":"Am J Epidemiol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19891115)64:10<2035::AID-CNCR2820641012>3.0.CO;2-L","article-title":"The influence of surgical trauma on experimental metastasis","volume":"64","author":"Murthy","year":"1989","journal-title":"Cancer"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/1097-0142(19941015)74:8<2347::AID-CNCR2820740820>3.0.CO;2-6","article-title":"Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? A 10-year follow-up study","volume":"74","author":"Hammarsten","year":"1994","journal-title":"Cancer"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/cncr.11710","article-title":"Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia","volume":"98","author":"Chokkalingam","year":"2003","journal-title":"Cancer"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1089\/end.2016.0696","article-title":"Transurethral resection of prostate and bleeding: a prospective, randomized, double-blind placebo-controlled trial to see the efficacy of short-term use of finasteride and dutasteride on operative blood loss and prostatic microvessel density","volume":"31","author":"Bansal","year":"2017","journal-title":"J Endourol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4111\/icu.2017.58.3.186","article-title":"Urethral strictures after bipolar transurethral resection of prostate may be linked to slow resection rate","volume":"58","author":"Tan","year":"2017","journal-title":"Investig Clin Urol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1590\/S1677-5538.IBJU.2014.0500","article-title":"Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate","volume":"42","author":"Tao","year":"2016","journal-title":"Int Braz J Urol"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bju.12181","article-title":"Transurethral enucleation and resection of the prostate vs transvesical prostatectomy for prostate volumes >80\u200amL: a prospective randomized study","volume":"112","author":"Ou","year":"2013","journal-title":"BJU Int"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5173\/ceju.2013.03.art13","article-title":"Conventional monopolar transurethral resection of prostate in patients with large prostate (>\/=80 grams)","volume":"66","author":"Yucel","year":"2013","journal-title":"Cent European J Urol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.juro.2012.10.117","article-title":"Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup","volume":"189","author":"Zhu","year":"2013","journal-title":"J Urol"},{"issue":"(11 Pt C)","key":"R22-20230914","doi-asserted-by":"crossref","first-page":"E864","DOI":"10.1111\/j.1464-410X.2012.11381.x","article-title":"Comparison of transurethral enucleation with bipolar and transurethral resection in saline for managing benign prostatic hyperplasia","volume":"110","author":"Hirasawa","year":"2012","journal-title":"BJU Int"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urology.2012.02.078","article-title":"Two-year outcome of high-risk benign prostate hyperplasia patients treated with transurethral prostate resection by plasma kinetic or conventional procedure","volume":"80","author":"Lv","year":"2012","journal-title":"Urology"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/oxfordjournals.aje.a010090","article-title":"Role of transurethral resection of the prostate in population-based prostate cancer incidence rates","volume":"150","author":"Merrill","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11255-015-1146-2","article-title":"Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review","volume":"48","author":"Al-Khalil","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-5347(01)63951-X","article-title":"Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer","volume":"159","author":"Levine","year":"1998","journal-title":"J Urol"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0090-4295(98)00574-3","article-title":"Prostate cancer detection: relationship to prostate size","volume":"53","author":"Chen","year":"1999","journal-title":"Urology"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.urology.2014.04.006","article-title":"Prostate size and adverse pathologic features in men undergoing radical prostatectomy","volume":"84","author":"Hong","year":"2014","journal-title":"Urology"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.eururo.2006.02.006","article-title":"Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study","volume":"49","author":"Zlotta","year":"2006","journal-title":"Eur Urol"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1464-410X.2010.09356.x","article-title":"The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer","volume":"106","author":"Krupski","year":"2010","journal-title":"BJU Int"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0090-4295(99)80160-5","article-title":"The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration","volume":"46","author":"Monda","year":"1995","journal-title":"Urology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901180-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:34:34Z","timestamp":1694720074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901180-00010"}},"subtitle":["A population-based study"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013897","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}